cysteamine has been researched along with d-alpha tocopherol in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (40.91) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alving, CR; Copeland, ES; Grenan, MM | 1 |
| Damen, J; Konings, AW; Trieling, WB | 1 |
| Schulman, JD | 1 |
| Evstigneeva, RP; Fedorova, LM; Miagkova, GI; Morenkova, SA; Tabutsadze, TU | 1 |
| Dordoni, B; Gazzard, BG; Hughes, RD; Portmann, B; Williams, R | 1 |
| Ivanov, II; Vertushkov, VT | 1 |
| Bolebruch, C; Cerni, C; Dudczak, R; Lenzhofer, R; Magometschnigg, D; Moser, K | 1 |
| Ahmad Khan, H; Al-Deeb, S; Al-Moutairy, K; Tariq, M | 1 |
| Anzai, K; Miura, Y; Ozawa, T; Urano, S | 1 |
| Kitagawa, Y; Suzuki, K; Watanabe, T; Yoneda, A | 1 |
| Akçay, A; Ateşşahin, A; Bucak, MN; Tekin, N; Varişli, O; Yüce, A | 1 |
| Chauhan, A; Fentzke, RC; Hsu, KH | 1 |
| Cui, W; Jiao, GZ; Li, H; Li, Q; Tan, JH; Wang, TY; Zhu, J | 1 |
| Bhattacharya, A; Chauhan, A; Dixon, P; Fentzke, RC; Hazra, S; Konar, A | 1 |
| Chauhan, A; Dixon, P; Powell, K | 1 |
| Chauhan, A; Christopher, K; Dixon, P; Jovic, N | 1 |
| Chauhan, A; Dixon, P | 1 |
| Anchordoquy, JM; Anchordoquy, JP; Campagna, A; Carranza-Martín, AC; Furnus, CC; Lombardo, DM; Luchetti, C; Nikoloff, N; Pascua, AM; Seoane, A | 1 |
| Kohli, R; Lin, CH | 1 |
4 review(s) available for cysteamine and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Genetic disorders of glutathione and sulfur amino-acid metabolism. New biochemical insights and therapeutic approaches.
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids, Sulfur; Ascorbic Acid; Cysteamine; Cystinosis; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Glutathione Synthase; Homocystinuria; Humans; Leukocytes; Vitamin E | 1980 |
Cysteamine attenuates iminodipropionitrile (IDPN) induced dyskinesia in rats.
Topics: Animals; Brain; Cysteamine; Dyskinesia, Drug-Induced; Glutathione; Male; Nervous System; Neurotoxins; Nitriles; Rats; Rats, Sprague-Dawley; Vitamin E | 1995 |
Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
Topics: Adolescent; Alanine Transaminase; Antioxidants; Bariatric Surgery; Child; Child, Preschool; Cysteamine; Cystine Depleting Agents; Delayed-Action Preparations; Diet; Humans; Hypoglycemic Agents; Infant; Infant, Newborn; Life Style; Liver Cirrhosis; Metformin; Non-alcoholic Fatty Liver Disease; Pediatric Obesity; Vitamin E | 2020 |
1 trial(s) available for cysteamine and d-alpha tocopherol
| Article | Year |
|---|---|
Letter: Treatment of paracetamol poisoning.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Cysteamine; Humans; Injections, Intravenous; Poisoning; Prospective Studies; Rats; Time Factors; Vitamin E | 1974 |
17 other study(ies) available for cysteamine and d-alpha tocopherol
| Article | Year |
|---|---|
Light-induced leakage of spin label marker from liposomes in the presence of phototoxic phenothiazines.
Topics: Antipsychotic Agents; Cysteamine; Light; Liposomes; Phenothiazines; Spin Labels; Vitamin E | 1976 |
Protection of liposomal lipids against radiation induced oxidative damage.
Topics: Animals; Cysteamine; Fatty Acids, Unsaturated; Glutathione; Liposomes; Membrane Lipids; Mice; Oxygen; Peroxides; Radiation-Protective Agents; Sonication; Vitamin E; X-Rays | 1979 |
Approaches to the treatment of inborn errors of sulphur amino acid and peptide metabolism.
Topics: Amino Acids, Sulfur; Ascorbic Acid; Aspirin; Cysteamine; Cystinosis; Dipyridamole; Glutathione; Glutathione Synthase; Homocystinuria; Humans; Metabolism, Inborn Errors; Pyridoxine; Vitamin E | 1979 |
[Effect of vagotomy, alpha-tocopherol and arachidene on lipid peroxidation in various areas of the gastroduodenal zone in rats with experimental peptic ulcer].
Topics: Animals; Anti-Ulcer Agents; Cysteamine; Drug Evaluation, Preclinical; Duodenal Ulcer; Duodenum; Fatty Acids, Unsaturated; Free Radicals; Gastric Mucosa; Lipid Peroxides; Male; Oxidation-Reduction; Rats; Rats, Inbred Strains; Stomach; Vagotomy; Vitamin E | 1987 |
Protection of rats against the hepatotoxic effect of paracetamol.
Topics: Acetaminophen; Administration, Oral; Animals; Cysteamine; Cytochrome P-450 Enzyme System; Drug Interactions; Glutathione; Injections, Intraperitoneal; Liver; Male; Microsomes, Liver; Necrosis; Propranolol; Rats; Thioctic Acid; Vitamin E | 1974 |
[Formation of fluorescent pigments in lipids].
Topics: Aldehydes; Animals; beta-Aminoethyl Isothiourea; Cystamine; Cysteamine; Epinephrine; Ethers, Cyclic; Fluorescence; Gallic Acid; Histamine; Hydroxylamines; Intestine, Small; Ketones; Lipid Metabolism; Male; Mice; Oleic Acids; Peroxides; Pigments, Biological; Radiation-Protective Agents; Serotonin; Spectrum Analysis; Spleen; Temperature; Tryptamines; Vitamin E | 1973 |
Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances.
Topics: Animals; Antioxidants; Cysteamine; Cysteine; Doxorubicin; Glutathione; Heart; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Myocardium; Vitamin E | 1983 |
In vivo electron paramagnetic resonance studies on oxidative stress caused by X-irradiation in whole mice.
Topics: Animals; Catalase; Cysteamine; Electron Spin Resonance Spectroscopy; Erythrocytes; Female; Glutathione Peroxidase; Kinetics; Lipoproteins, LDL; Liver; Mice; Nitrogen Oxides; Oxidation-Reduction; Oxidative Stress; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E; X-Rays | 1997 |
Effects of oxygen concentration and antioxidants on the in vitro developmental ability, production of reactive oxygen species (ROS), and DNA fragmentation in porcine embryos.
Topics: Animals; Antioxidants; Blastocyst; Cleavage Stage, Ovum; Comet Assay; Cysteamine; DNA Fragmentation; Dose-Response Relationship, Drug; Embryonic Development; Fertilization in Vitro; Hydrogen Peroxide; Oocytes; Oxygen; Reactive Oxygen Species; Swine; Vitamin E | 2004 |
The influence of trehalose, taurine, cysteamine and hyaluronan on ram semen Microscopic and oxidative stress parameters after freeze-thawing process.
Topics: Animals; Antioxidants; Catalase; Cell Survival; Cryopreservation; Cryoprotective Agents; Cysteamine; Glutathione; Glutathione Peroxidase; Hyaluronic Acid; Male; Malondialdehyde; Oxidative Stress; Semen; Semen Preservation; Sheep; Sperm Motility; Taurine; Trehalose; Vitamin E | 2007 |
Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses.
Topics: Administration, Ophthalmic; Biological Availability; Biological Transport; Contact Lenses; Cornea; Cysteamine; Diffusion; Drug Delivery Systems; Drug Stability; Feasibility Studies; Hydrogels; Models, Theoretical; Ophthalmic Solutions; Silicones; Time Factors; Vitamin E | 2013 |
Non-frozen preservation protocols for mature mouse oocytes dramatically extend their developmental competence by reducing oxidative stress.
Topics: alpha-Tocopherol; Animals; Antioxidants; Blastocyst; Cells, Cultured; Cellular Senescence; Cysteamine; Cystine; Embryonic Development; Female; Glutathione; Mice; Oocytes; Organ Preservation Solutions; Oxidative Stress; Pregnancy; Temperature; Tissue Preservation | 2014 |
In vitro drug release and in vivo safety of vitamin E and cysteamine loaded contact lenses.
Topics: Animals; Contact Lenses, Hydrophilic; Cornea; Cysteamine; Cystine Depleting Agents; Cystinosis; Diffusion; Drug Delivery Systems; Drug Liberation; Drug Stability; Female; Male; Models, Animal; Models, Biological; Oxidation-Reduction; Rabbits; Time Factors; Vitamin E | 2018 |
Novel approaches for improving stability of cysteamine formulations.
Topics: Administration, Ophthalmic; Antioxidants; Ascorbic Acid; Catalase; Cysteamine; Cystine Depleting Agents; Drug Compounding; Drug Packaging; Drug Stability; Hydrophobic and Hydrophilic Interactions; Ophthalmic Solutions; Oxidation-Reduction; Oxygen; Soybean Oil; Technology, Pharmaceutical; Time Factors; Vitamin E | 2018 |
Spectroscopy of Oxygen-Sensitive Material for Measuring Contact Lens Oxygen Transmissibility.
Topics: Biological Transport; Contact Lenses, Hydrophilic; Cysteamine; Oxidation-Reduction; Oxygen; Permeability; Printing, Three-Dimensional; Spectrophotometry, Ultraviolet; Vitamin E | 2019 |
Carbon Black Tinted Contact Lenses for Reduction of Photophobia in Cystinosis Patients.
Topics: Animals; Antihypertensive Agents; Contact Lenses, Hydrophilic; Corneal Diseases; Cysteamine; Cystine Depleting Agents; Cystinosis; Drug Delivery Systems; Elastic Modulus; Microscopy, Electron, Scanning; Photophobia; Rabbits; Refractometry; Soot; Spectrophotometry, Ultraviolet; Timolol; Vitamin E; Vitamins | 2019 |
Effects of EPA on bovine oocytes matured in vitro with antioxidants: Impact on the lipid content of oocytes and early embryo development.
Topics: Animals; Antioxidants; Cattle; Cysteamine; Cystine Depleting Agents; Eicosapentaenoic Acid; Embryo Culture Techniques; Embryonic Development; In Vitro Oocyte Maturation Techniques; Lipids; Oocytes; Vitamin E | 2020 |